Abbott breaks US corporate bonds silence
Acquisitive pharmaceuticals company Abbott Laboratories breathed some life into the US market this week with a $3bn issue that marked the biggest corporate bond sale in a month amid the strongest week for issuance since the start of April
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts